| Literature DB >> 35494950 |
Muhammad Amer Awan1, Syed Zohaib Maroof Hussain2, Fiza Shaheen1, Mian Bilal Humayun1, Nain Tara Zeb3, Bushra Ayub4, M A Rehman Siddiqui5.
Abstract
Introduction This study aims to evaluate the primary anatomical success and visual outcomes of 25-gauge pars plana vitrectomy (25g PPV) in patients with rhegmatogenous retinal detachment (RRD) in Pakistan. Design This is a five-year retrospective, interventional cohort study conducted at tertiary care hospitals in Pakistan from October 2013 to October 2018. Methods This is a retrospective, interventional cohort study of 418 consecutive patients with RRD who underwent 25g PPV. All surgeries were performed by two experienced surgeons at tertiary care hospitals in Pakistan. Consecutive patients who underwent 25g PPV surgery as the treatment for RRD from October 2013 to October 2018 were included. We excluded patients who had a history of previous retinal surgery or did not complete the 4-8 weeks of primary outcome visit. We used the Statistical Package for the Social Sciences (SPSS) version 23.0 (IBM Corporation, Armonk, NY, USA) for statistical analysis. A p-value of <0.05 was considered significant. Results We identified 452 patients through the coding system of our hospitals who underwent 25g PPV surgery for RRD during the study period. A total of 441 patient files were reviewed for the study, of which 418 patients met the criteria for final analysis. The mean age was 49 ± 15.8 years. There was a higher number of males (n = 284, 67.9%). In our study, 186 (44.4%) patients were phakic at the time of presentation. The macula was detached in 361 (86.4%) patients. At the primary outcome visit (4-8 weeks of follow-up), the primary anatomical success rate was 89.47%. The most common cause of failure was proliferative vitreoretinopathy (PVR) (n = 20), followed by missed breaks (n = 5). Conclusions The surgical outcomes of RRD with 25g PPV surgery in our study were similar to the outcomes reported in the developed world. We propose a prospective multicenter national study to prospectively evaluate the risk factors for RRD surgical failure in the Pakistani population.Entities:
Keywords: 25 gauge; pars plana vitrectomy (ppv); proliferative vitreoretinopathy; retinal detachment surgery; surgical audit
Year: 2022 PMID: 35494950 PMCID: PMC9038210 DOI: 10.7759/cureus.23437
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Figure 1Flowchart of patient flow in the study.
RRD: rhegmatogenous retinal detachment
Baseline characteristics of the enrolled patients.
PVD: posterior vitreous detachment, PVR: proliferative vitreoretinopathy
| Characteristics (n = 418) | Frequency | Percentage (%) |
| Gender | ||
| Male | 284 | 68 |
| Female | 134 | 32 |
| Age (years) (median, IQR = 38, 60) | ||
| 5-15 | 17 | 4.1 |
| 16-25 | 13 | 3.1 |
| 26-50 | 167 | 40 |
| 51-65 | 165 | 39.6 |
| 66-80 | 55 | 13.2 |
| Status of lens | ||
| Phakia | 186 | 44.4 |
| Pseudophakia + aphakia | 232 | 55.5 |
| Status of the macula | ||
| Off | 361 | 86.4 |
| On | 57 | 13.6 |
| PVD | ||
| Present | 324 | 77.5 |
| Absent | 94 | 22.4 |
| PVR | ||
| <PVR grade C | 323 | 77.3 |
| PVR grade C | 95 | 22.7 |
Intraoperative parameters of the enrolled patients.
HST: horseshoe tear, GRT: giant retinal tear
| Characteristics (n = 418) | Frequency | Percentage (%) |
| Types of breaks | ||
| Round holes | 115 | 27.5 |
| HST | 95 | 22.7 |
| GRT | 25 | 5.9 |
| Dialysis | 3 | 0.7 |
| Mixed | 157 | 37.5 |
| No tear | 23 | 5.5 |
| Number of breaks | ||
| No tear identified | 23 | 5.5 |
| Single | 106 | 25.4 |
| 2-5 | 221 | 52.9 |
| 6-10 | 42 | 10 |
| >10 | 25 | 6 |
Figure 2Distribution of tamponade agent used.
SF6: sulfur hexafluoride, C2F6: hexafluoroethane, C3F8: octafluoropropane, SO: silicon oil
Comparison of pre- and postoperative visual acuity.
*Median (IQR) VA in log-MAR
RD: retinal detachment, N: number of patients
| Time (N) | Macula-on RD* | Macula-off RD* | P-value |
| Preoperative (418) | 0.6 (0.2-2) | 2 (2-3) | <0.0001 |
| Two months (417) | 1 (0.6-2) | 1 (0.7-2) | 0.579 |
| Six months (322) | 0.35 (0.1-0.8) | 0.70 (0.3-2) | 0.002 |
Frequency of tamponade agent used.
PVR: proliferative vitreoretinopathy, SF6: sulfur hexafluoride, C2F6: hexafluoroethane, C3F8: octafluoropropane, SO: silicon oil
| SF6 | C2F6 | C3F8 | SO | Densiron | Total | P-value | |
| <PVR grade C | 104 (32.2%) | 42 (13%) | 72 (22.3%) | 99 (30.7%) | 6 (1.9%) | 323 (100%) | <0.001 |
| PVR grade C | 3 (3.2%) | 2 (2.1%) | 5 (5.3%) | 83 (87.4%) | 2 (2.1%) | 95 (100%) |
Studies reporting RRD outcomes with 25g vitrectomy.
SB: scleral buckling, NR: not reported, PO: primary outcome
| Author | Year | Country | Study design | Sample size | Macula-off (%) | PVR C included | Silicon oil (%) | Time at PO assessment (in weeks) | Success rate (%) |
| Mura et al. [ | 2009 | Netherlands | Retrospective | 131 | 59.5 | No | 3.1 | 12 | 92.4 |
| Kunikata et al. [ | 2010 | Japan | Retrospective | 84 | 53.6 | No | 0 | 12 | 95.2 |
| Iwahashi et al. [ | 2013 | Japan | Retrospective | 27 | NR | Yes | 11.1 | <52 | 77.8 |
| Dell’Omo et al. [ | 2013 | Netherlands | Retrospective | 41 | 58.5 | No | NR | 24 | 92.6 |
| Susskind et al. [ | 2016 | Germany | Prospective | 25 | 72 | No | NR | 24 | 65 |
| Rizzo et al. [ | 2017 | Italy | Prospective | 20 | 85 | No | 30 | 24 | 85 |
| Romano et al. [ | 2017 | Italy | Prospective | 15 | 60 | Yes | NR | 24 | 93 |
| Sborgia et al. [ | 2019 | Italy | Prospective | 46 | 52.1 | No | NR | 52 | 95.7 |
| Present study | 2020 | Pakistan | Retrospective | 418 | 86.4 | Yes | 44 | 8 | 89.4 |